<HTML xmlns="http://www.w3.org/TR/REC-html40" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:v="urn:schemas-microsoft-com:vml" xmlns:w="urn:schemas-microsoft-com:office:word"><head><META content="text/html; charset=us-ascii" http-equiv="Content-Type">
<META content="text/html; charset=us-ascii" HTTP-EQUIV="Content-Type">
<meta content="Microsoft Word 12 (filtered medium)" name=Generator>
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<style>
<!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
p
{mso-style-priority:99;
margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:navy;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Times New Roman","serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.25in 1.0in 1.25in;}
div.WordSection1
{page:WordSection1;}
-->
</style>
<!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head><BODY>
<DIV>
<DIV>
<DIV>
<div class=WordSection1>
<p class=MsoNormal><span style='font-size:11.0pt;color:#1F497D'><o:p> </o:p></span></p>
<p class=MsoNormal><span style='font-size:11.0pt;color:#1F497D'><o:p> </o:p></span></p>
<div>
</DIV>
<DIV><BR><BR></DIV>
<DIV STYLE="FONT-FAMILY: Courier New; FONT-SIZE: 9pt"><EM><FONT FACE="Arial" SIZE="2">The Department of Environmental Protection values your feedback as a customer. DEP Secretary Mimi Drew is committed to continuously assessing and improving the level and quality of services provided to you. Please take a few minutes to comment on the quality of service you received. Simply click on <A HREF="http://survey.dep.state.fl.us/?refemail=Laurie.Tenace@dep.state.fl.us" TARGET="_blank">this link to the DEP Customer Survey</A>. Thank you in advance for completing the survey.</FONT></EM></DIV>
<DIV STYLE="FONT-FAMILY: Courier New; FONT-SIZE: 9pt"><EM><FONT FACE="Arial" SIZE="2"></FONT></EM></DIV>
<DIV STYLE="FONT-FAMILY: Courier New; FONT-SIZE: 9pt">
<p class=MsoNormal style='margin-left:.5in'><b><span style='font-size:10.0pt;
font-family:"Tahoma","sans-serif"'>From:</span></b><span style='font-size:10.0pt;
font-family:"Tahoma","sans-serif"'> Howard Anderson [mailto:ndboph@btinet.net] <br>
<b>Sent:</b> Friday, October 22, 2010 11:39 AM<br>
<b>To:</b> 'Matthew C. Mireles'; 'Stevan Gressitt'; 'pharmwaste'<br>
<b>Cc:</b> 'Caverly, Mark W'; Joe Cappello; Jackie L Henderson; Bonnie Thom;
'Bonnie Thom'; 'David Lindell'; 'Dewey'; Gary Dewhirst; 'Gayle Ziegler'; Gayle
Ziegler; 'Gerald R. Johnson'; 'Judy Swisher'; Justin Stubstad; 'Laurel
Haroldson (E-mail)'; 'Rick Detwiller'; william.grosz@netzero.net<br>
<b>Subject:</b> RE: [Pharmwaste] DEA and Post consumer medications<o:p></o:p></span></p>
</div>
</div>
<p class=MsoNormal style='margin-left:.5in'><o:p> </o:p></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>Dear Dr. Gressitt Mr. Mireles and
others:<o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'><o:p> </o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>Please do not get the DEA into the
collection business. They should be writing simple regulations to allow
Pharmacies, Boards of Pharmacy, Pharmacy Organizations, Return Companies,
Police Departments and others to do the collection and disposal.<o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'><o:p> </o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>If the DEA wants data there should
be a simple online data collection tool that can be used by everyone. It should
have a big section for unidentified medication.<o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'><o:p> </o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>Keep in mind that these are
consumer medications, they are a very small part of what is manufactured in the
first place, and we want them off the street when they are no longer being used
as prescribed.<o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'><o:p> </o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>Please minimize the </span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:black'>(hazardous,
nonhazardous, household waste) concerns and make it as easy as possible to get
these to disposal sites, or you will only succeed in impeding the process.
Forget about the waste generator idea, these were generated by the manufacturer
when he made the stuff in the first place. These are all going someplace now,
so do your research once the new methods are in place and then come up with
constructive tweaks, once you have identified significant issues.<o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'><o:p> </o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'>We have a pretty good ongoing
program in North Dakota between our pharmacies and the Attorney General’s
office, with participation by many local sheriffs and police departments.
Please do not sabotage it by adding several more layers of complexity to the
process.<o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'><o:p> </o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'>Sincerely,<o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'><o:p> </o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'>Howard</span><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:navy'><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'><o:p> </o:p></span></p>
<div>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>Howard C. Anderson, Jr.,R.Ph.</span><span style='color:navy'><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>Executive Director</span><span style='color:navy'><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>North Dakota Board of Pharmacy</span><span style='color:navy'><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>1906 E. Broadway Ave.</span><span style='color:navy'><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>P.O. Box 1354</span><span style='color:navy'><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>Bismarck, ND 58502-1354</span><span style='color:navy'><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>Phone (701) 328-9535</span><span style='color:navy'><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>Fax (701) 328-9536</span><span style='color:navy'><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:navy'>Web site www.nodakpharmacy.com</span><o:p></o:p></p>
</div>
<div>
<div align=center class=MsoNormal style='margin-left:.5in;text-align:center'>
<hr align=center size=2 width="100%">
</div>
<p class=MsoNormal style='margin-left:.5in'><b><span style='font-size:10.0pt;
font-family:"Tahoma","sans-serif"'>From:</span></b><span style='font-size:10.0pt;
font-family:"Tahoma","sans-serif"'> pharmwaste-bounces@lists.dep.state.fl.us
[mailto:pharmwaste-bounces@lists.dep.state.fl.us] <b>On Behalf Of </b>Matthew
C. Mireles<br>
<b>Sent:</b> Friday, October 22, 2010 10:11 AM<br>
<b>To:</b> Stevan Gressitt; pharmwaste<br>
<b>Subject:</b> Re: [Pharmwaste] DEA not collaborating with american medicine
chest</span><o:p></o:p></p>
</div>
<p class=MsoNormal style='margin-left:.5in'><o:p> </o:p></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>Dr. Gressitt, we attended a special debrief in Houston with local
DEA agents and we learned about the same thing---nobody knows what's going
on. I understand that DEA field officers are convening in DC with
Cathy Gallagher and others to get a handle of the new Secure and Responsible
Drug Dispoal Act, 2010. Our impression is that the DEA may want to
unilaterally lead this campaign but they are strictly concerned with drug
diversion. The purposes of the debrief was to recap on the "success"
of drug collection in Harris Co. and to solicit ideas from the audience of
mostly law enforcement about concerns and questions that should be asked in DC
next week. <o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'> <o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>here is our list:<o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'> <o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>1. how does the DEA define unused and expired
medicines? (hazardous, nonhazardous household waste, etc.)<o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>2. what collection mechanism would be preferred by the DEA?<o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>3. what level of accountabilty must be set up to handle and
transfer consumers' unwanted narcotics<o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>4. would the DEA only collect controlled substances?
what about other prescription drugs and legacy drugs?<o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>5. how would the DEA measure its program and any oversight
of other "agencies" approved to collect controlled substances?<o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>6. what data would be collected, who will collect data,
etc.?<o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>7. would the DEA have manpower and resources to enact the
new law?<o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>8. where is the funds coming from?<o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>9. would the DEA office be considered a "waste
generator", depending on chosen classification or definition of UEMs.<o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'> <o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>We collected about 3 tons in the county. The DEA local field
office will destroy them via contracted reverse distributor. In
Houston, there is interest for only 2 annual events. The Sheriff
department is already understaff and may not be able to provide
personnel. For a city of 4 million, only one police station
participated. The chief complain was that there wasn't sufficient time
and DEA planners want to invest more into promotion and publicity. The
prevailing attitude seems to be setting up secure collection bins for drop offs
at designated locations. The speaker thought direct mailback would
invite more tampering and diversion. There seems to be some
misunderstanding about the sources of unwanted meds and whether consumers'
controlled substances at home, workplace or on person should be addressed
relative to the DEA's concept of a strict, closed-loop system with registrants,
etc. <o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'> <o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'> <o:p></o:p></span></p>
<p style='margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>Matthew Mireles<o:p></o:p></span></p>
<blockquote style='border:none;border-left:solid blue 1.5pt;padding:0in 0in 0in 4.0pt;
margin-left:0in;margin-top:5.0pt;margin-bottom:5.0pt'>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'><o:p> </o:p></span></p>
<p class=MsoNormal style='mso-margin-top-alt:0in;margin-right:0in;margin-bottom:
12.0pt;margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'>-----Original Message----- <br>
From: Stevan Gressitt <br>
Sent: Oct 22, 2010 7:49 AM <br>
To: pharmwaste <br>
Subject: [Pharmwaste] DEA not collaborating with american medicine chest <o:p></o:p></span></p>
<div>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'>I learned at a conference this
week for what it is worth that DEA is not collaborating with the american
medicinechest drug return in november despite any sponsor claims. There is also
a newspaper article I found that sclaims incorrectly that the new law allows a
pharmacy to collect controlled drugs. Strange things coming out of the
woodwork.<o:p></o:p></span></p>
</div>
<div>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'><br clear=all>
<o:p></o:p></span></p>
</div>
<div>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'>Stevan Gressitt, M.D.<br>
Faculty Associate, University of Maine Center on Aging<br>
Academic Member, Athens Institute for Education and Research<o:p></o:p></span></p>
</div>
<div>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'>Athens, Greece<o:p></o:p></span></p>
</div>
<div>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'>Founding Director, International
Institute for Pharmaceutical Safety<br>
University of New England, College of Pharmacy<br>
Department of Pharmaceutical Sciences <br>
Associate Professor of Clinical Psychiatry<br>
University of New England, College of Osteopathic Medicine<br>
716 Stevens Avenue <br>
Portland, Maine 04103<br>
<a href="mailto:gressitt@gmail.com" target="_blank">gressitt@gmail.com</a>
<br>
Cell: 207-441-0291 <o:p></o:p></span></p>
</div>
<div>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'><a href="http://www.benzos.une.edu/" target="_blank">www.benzos.une.edu</a> <o:p></o:p></span></p>
</div>
<div>
<p class=MsoNormal style='mso-margin-top-alt:0in;margin-right:0in;margin-bottom:
12.0pt;margin-left:.5in'><span style='font-size:10.0pt;font-family:"Arial","sans-serif";
color:black'><a href="http://www.safemeddisposal.com/" target="_blank">www.safemeddisposal.com/</a><o:p></o:p></span></p>
</div>
<p class=MsoNormal style='margin-left:.5in'><span style='font-size:10.0pt;
font-family:"Arial","sans-serif";color:black'><o:p> </o:p></span></p>
</blockquote>
</div>
</DIV></DIV></DIV></BODY></HTML>